Irradiation for intimal hyperplasia: Implications for peripheral arterial bypass

Journal of the American College of Surgeons

Volumn 190, Issue 3, 2000, Pages 364-370

  Illig, Karl A ^a   Soni, Arvind B ^a   Williams, Jacqueline ^a   Shortell, Cynthia K ^a   Okunieff, Paul ^a   Schell, Michael ^a   Rubin, Philip ^a   Green, Richard M ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY ANASTOMOSIS; ARTERY BYPASS; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; BYPASS SURGERY; HUMAN; IRRADIATION; PRIORITY JOURNAL; RADIOSENSITIVITY; REVIEW;

ANGIOPLASTY, BALLOON; ANIMALS; ARTERIOSCLEROSIS; HUMANS; HYPERPLASIA; MUSCLE, SMOOTH, VASCULAR; TUNICA INTIMA; VASCULAR DISEASES; VASCULAR SURGICAL PROCEDURES;

EID: 0033996542     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(99)00271-9     Document Type: Review

References (59)

1. Allaire E, Clowes AW. Endothelial cell injury in cardiovascular surgery: the intimai hyperplastic response. Ann Thor Surg 1997;63:582-591.
2. Purcell C, McGeachie J, Tennant M. Neo-intimal hyperplasia in vascular grafts and its implications for autologous arterial grafting. Ann R Coll Surg Engl 1997;79:164-168.
3. Chervu A, Moore WS. An overview of intimai hyperplasia. Surg Gyn Oncol 1990;171:433-447.
4. Davies MG, Hagen PO. Pathophysiology of vein graft failure: a review. Eur J Vasc Endovasc Surg 1995;9:7-18.
5. Rubin P, Williams JP, Riggs PN, et al. Cellular and molecular mechanisms of radiation inhibition of restenosis. Part I: role of the macrophage and platelet-derived growth factor. Int J Radiat Oncol Biol Phys 1998;40:929-941.
6. Kovalic JJ, Perez CA. Radiation therapy following keloidectomy: a 20-year experience. Int J Radiat Oncol Biol Phys 1989;17:77.
7. Gregoritch SJ. Prevention of heterotopic ossification: a paradigm for the evolving role of radiation therapy in benign disease. Int J Radiat Oncol Biol Phys 1996;36:981-983.
8. Rubin P, Williams J, Schell M, et al. Radiation inhibition of arterial restenosis: a new frontier. Acta Oncol 38:407-424.
9. Gajdusek CM, Tian H, London S, et al. Gamma radiation effect on vascular smooth muscle cells in culture. Int J Radiat Oncol Biol Phys 1996;36:821-828.
10. Rubin P, Soni A, Williams JP. The molecular and cellular basis for the radiation treatment of benign proliferative diseases. Semin Radiat Oncol 1999;9:203-214.
11. Brenner DJ, Miller RC, Hall EJ. The radiobiology of intravascular radiation. Int J Radiat Oncol Biol Phys 1996;36:805-810.
12. Wiedermann JG, Leavy JA, Amols H, et al. Effects of high-dose intracoronary irradiation on vasomotor function and smooth muscle histopathology. Am J Physiol 1994;267:H125-132.
13. Fortunado JE, Glagov S, Bassiouny HS. Irradiation for the treatment of intimal hyperplasia. Ann Vasc Surg 1998;12:495-503.
14. Fajardo LF, Stewart JR. Radiation and the coronary arteries: friend or foe? Int J Radiat Oncol Biol Phys 1996;36:971-972.
15. Friedman M, Felton L, Byers S. The antiatherogenic effect of iridium-192 upon the cholesterol-fed rabbit. J Clin Invest 1964;43:185-192.
16. Friedman M, Byers SO. Effects of iridium-192 radiation on thrombo-atherosclerotic plaque in the rabbit aorta. Arch Pathol 1965;80:285-291.
17. Wechsler Z, Gotsman MS, Okon E, et al. Inhibition by irradiation of smooth muscle cell proliferation in the de-endothelialized rat aorta. In: Frontiers in Radiation Biology: Proceedings of the 21st Annual European Society for Radiation Biology; Oct 1988; Tel Aviv, Israel. New York: VCH Publishers; 1990:133-138.
18. Schwartz RS, Koval TM, Edwards WD, et al. Effect of external beam irradiation on neointimal hyperplasia after experimental coronary artery injury. J Am Coll Cardiol 1992;19:1106-1113.
19. Schell MC, Rosenzweig DP, Weaver K, et al. Characterization of the dose perturbation in tissue by stents as a function of external beam energy. CVRM 1999;1:154-159.
20. Wiedermann JG, Marboe C, Amols H, et al. Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. J Am Coll Cardiol 1994;23:1491-1498.
21. Wiedermann JG, Marboe C, Amols H, et al. Intracoronary irradiation markedly reduces neointial proliferation after balloon angioplasty in swine: persistent benefit at 6-month follow-up. J Am Coll Cardiol 1995;25:1451-1456.
22. Waksman R, Robinson KA, Crocker IR, et al. Intracoronary radiation before stent implantation inhibits neointima formation in stented porcine coronary arteries. Circulation 1995;92: 1383-1386.
23. Waksman R, Robinson KA, Crocker IR, et al. Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine. Circulation 1995;91: 1533-1539.
24. Waksman R, Robinson KA, Crocker IR, et al. Intracoronary low-dose beta-irradiation inhibits neointima formation in swine after coronary artery balloon injury in the swine restenosis model. Circulation 1995;92:3025-3031.
25. Shimotakahara S, Mayberg MR. Gamma irradiation inhibits neointimal hyperplasia in rats after arterial injury. Stroke 1994; 25:424-428.
26. Sarac TP, Riggs PN, Williams JP, et al. The effects of low-dose radiation on intimai hyperplasia. J Vasc Surg 1995;22:17-24.
27. Mayberg MR, Luo Z, London S, et al. Radiation inhibition of intimal hyperplasia after arterial injury. Rad Res 1995;142:212.
28. Verin V, Popowski Y, Urban P, et al. Intra-arterial β irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model. Circulation 1995;92:2284-2290.
29. Andros G, Schneider PA, Harris RW. Radiation-induced arteritis. In: Ernst CB, Stanley JC, eds. Current therapy in vascular surgery. 3rd edition. St. Louis: Mosby Inc; 1995:133-137.
30. Tallman MP, Williams JP, Eagleton MJ, et al. Tolerance of normal rabbit femoral arteries to single high dose external beam irradiation. CVRM 1999;1:131-137.
31. Soni A, Illig KA, Williams JP, et al. Safety of externally irradiating PTFE and native vessel grafts following surgery. In press, Proc Adv Cardiovasc Radiat Ther.
32. Williams JP, Rubin P, Soni A, et al. Comparability of the external vs. internal location of radiation in inhibiting neointimal hyperplasia. Cardiovasc Radiat Med 1999;1:55-63.
33. Jani SK. Gamma vs. beta irradiation: which is superior? Cardiovasc Radiat Med 1999;1:102-106.
34. Kantor B, Ashai K, Holmes DR, et al. The experimental animal models for assessing treatment of restenosis. Cardiovasc Radiat Med 1999;1:48-54.
35. Bottcher HD, Schopohl B, Liermann D, et al. Endovascular irradiation - a new method to avoid recurrent stenosis after stent implantation in peripheral arteries: technique and preliminary results. Int J Rad Oncol Biol Phys 1994;29:183-186.
36. 192IR endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: 6 years of experience. Int J Rad Oncol Biol Phys 1996;36:835-840.
37. Parikh S, Nori D, Rogers D, et al. External beam radiation therapy to prevent postangioplasty dialysis access restenosis: a feasibility study. Cardiovasc Radiat Med 1999;1:36-41.
38. Waksman R, Crocker IA, Kikeri D, et al. Endovascular low dose irradiation for prevention of restenosis following angioplasty for treatment of narrowed arteriovenous dialysis grafts [abstract]. J Am Coll Cardiol 1996;27:214A.
39. Popowski Y, Verin V, Urban P. Endovascular beta-irradiation after percutaneous transluminal coronary balloon angioplasty. Int J Rad Oncol Biol Phys 1996;36:841-845.
40. Massullo V, Teirsein PS, Jani S, et al. Endovascular brachytherapy to inhibit coronary artery restenosis: an introduction to the Scripps coronary radiation to inhibit proliferation post stenting trial. Int J Rad Oncol Biol Phys 1996;36:973-975.
41. Teirstein PS, Massullo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-1703.
42. Teirstein PS, Massullo V, Jani S, et al. Two-year follow-up after catheter-based radiotherapy to inhibit coronary restensosis. Circulation 1999;99:243-247.
43. Waksman R. Intracoronary radiation therapy for restenosis prevention: status of the clinical trials. Cardiovasc Radiat Med 1999;1:20-29.
44. Newman AB, Siscovick DS, Manolio TA, et al. Ankle-arm index as a marker of atherosclerosis in the cardiovascular health study. Circulation 1993;88:837-845.
45. Fowkes FGR, Housley E, Cawood EHH, et al. Edinburgh artery study: prevalence of asymptomatic arterial disease in the general population. Int J Epidemiol 1991;20:384-392.
46. Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. J Clin Epidemiol 1992;45: 529-542.
47. Stanley JC, Barnes RW, Ernst CR, et al. Vascular surgery in the United States: workforce issues. J Vasc Surg 1996;23:172-181.
48. Becquemin JP, Cavillon A, Haiduc F. Surgical transluminal femoropopliteal angioplasty: multivariate analysis outcome. J Vasc Surg 1994;19:495-502.
49. Wilson SE, WoIf SL, Cross AP. Percutaneous transluminal angioplasty versus operation for peripheral atherosclerosis: report of a prospective randomized trial in a selected group of patients. J Vasc Surg 1989;9:1-9.
50. Johnston KW, Rae M, Hogg-Johnston SA, et al. 5-year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg 1987;206:403-413.
51. Golledge J, Ferguson K, Ellis M, et al. Outcome of femoropopliteal angioplasty. Ann Surg 1999;229:146-153.
52. Whyman MR, Ruckley CV. Should claudicants receive angioplasty or just exercise training? Cardiovasc Surg 1998;6:226-231.
53. Matsi PJ, Manninen HI. Complications of lower-limb percutaneous angioplasty: a prospective analysis of 410 procedures on 295 consecutive patients. Cardiovasc Interventional Radiol 1998;21:361-366.
54. Martin DR, Katz SG, Kohl RD, Qian D. Percutaneous transluminal angioplasty of infrainguinal vessels. Ann Vasc Surg 1999; 13:184-187.
55. Parsons RE, Suggs WD, Lee JJ, et al. Percutaneous transluminal angioplasty for the treatment of limb-threatening ischemia: Do the results justify an attempt before bypass grafting? J Vasc Surg 1998;28:1066-1071.
56. Brewster DC, LaSalle AJ, Robison JG, et al. Femoropopliteal graft failures: clinical consequences and success of secondary revascularization. Arch Surg 1983;118:1043-1047.
57. Caps MT, Cantwcll-Gab K, Bergelin RO, et al. Vein graft lesions: time of onset and rate of progression. J Vasc Surg 1995; 22:466-475.
58. Szilagyi DE, Elliott JP, Hageman JH, et al. Biologic fate of autogenous vein implants as arterial substitutes: clinical, angiographic, and histopathiologic observations in femoro-popliteal operations for atherosclerosis. Ann Surg 1973;178:232-246.
59. Illig KA, Shortell CK, Green RM. Lower extremity arterial occlusive disease. Cardiovasc Radiat Med 1999;30:288-296.